SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031446
Filing Date
2022-11-14
Accepted
2022-11-10 18:14:20
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 781067
2 ex31-1.htm EX-31.1 17717
3 ex31-2.htm EX-31.2 18154
4 ex32-1.htm EX-32.1 7054
5 ex32-2.htm EX-32.2 7195
  Complete submission text file 0001493152-22-031446.txt   3875437

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hils-20220930.xsd EX-101.SCH 26410
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hils-20220930_cal.xml EX-101.CAL 35608
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hils-20220930_def.xml EX-101.DEF 129570
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hils-20220930_lab.xml EX-101.LAB 273374
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hils-20220930_pre.xml EX-101.PRE 220164
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 486810
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41210 | Film No.: 221378947
SIC: 2834 Pharmaceutical Preparations